HHM develops when cancer cells secrete substances that disrupt normal calcium homeostasis. The most significant of these substances is PTHrP, which mimics the action of parathyroid hormone (PTH). PTHrP binds to PTH receptors in bones and kidneys, leading to increased bone resorption and reduced renal calcium excretion, thereby raising blood calcium levels.
